Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$63.83 - $80.0 $280,341 - $351,360
-4,392 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $337,525 - $392,864
4,392 New
4,392 $341,000
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $225,400 - $246,428
-2,800 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$76.38 - $86.03 $213,864 - $240,884
2,800 New
2,800 $236,000
Q3 2019

Oct 16, 2019

SELL
$81.4 - $89.78 $504,680 - $556,636
-6,200 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$73.44 - $82.41 $455,328 - $510,942
6,200 New
6,200 $473,000
Q1 2019

May 03, 2019

SELL
$64.48 - $81.31 $109,616 - $138,227
-1,700 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$61.45 - $77.8 $104,465 - $132,260
1,700 New
1,700 $112,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.